DXCM – DexCom | Premier Stocks League

DXCM DexCom

Official Name: DEXCOM, INC.
Headquarters: 6340 Sequence Dr, SAN DIEGO, CA, 92121 US
CEO: Kevin Sayer
Website: dexcom.com

Match Results

Date	League	Week	Opponent	Result	Score
2025-07-14	N-L 27	1	ICUI	Won by 3.118	2.167 - (0.951)
2025-07-15	INV C	1R	NOK	Won by 1.968	(0.496) - (2.464)
2025-07-21	N-L 27	2	GKOS	Won by 5.168	(0.702) - (5.870)
2025-07-28	N-L 27	3	MXL	Lost by 11.135	6.371 - 17.506
2025-07-29	INV C	2R	CROX	Won by 0.435	(0.825) - (1.260)
2025-08-04	N-L 27	4	MASI	Lost by 11.714	(12.476) - (0.762)
2025-08-07	PSL C	1R	PANW	Won by 1.610	(0.194) - (1.804)
2025-08-11	N-L 27	5	ICUI	Won by 14.250	3.364 - (10.886)
2025-08-12	INV C	3R	WGO	Lost by 3.565	2.675 - 6.240
2025-08-18	N-L 27	6	VSAT	Lost by 2.863	3.496 - 6.359
2025-08-21	PSL C	2R	OTIS	Lost by 0.332	(0.689) - (0.357)
2025-08-25	N-L 27	7	LOPE	Lost by 6.651	(4.226) - 2.425
2025-09-01	N-L 27	8	PLMR	Lost by 1.366	(0.695) - 0.671
2025-09-08	N-L 27	9	MODG	Won by 4.848	3.539 - (1.309)
2025-09-15	N-L 27	10	PLMR	Won by 4.816	(3.228) - (8.044)
2025-09-22	N-L 27	11	MNST	Lost by 5.408	(5.981) - (0.573)
2025-09-29	N-L 27	12	LOPE	Lost by 6.405	(3.603) - 2.802
2025-10-06	N-L 27	13	MODG	Won by 0.611	(0.149) - (0.760)
2025-10-13	N-L 27	14	MODG	Won by 3.897	(1.740) - (5.637)
2025-10-20	N-L 27	15	LOPE	Won by 2.613	4.987 - 2.374

Latest News

Yahoo - 2026-10-16

Vaso Stock Surges 149% in a Year: What's Behind the Rally? 🔗

VASO is gaining from higher equipment deliveries, growing deferred commissions and a sharper healthcare focus, though partner dependence and margin pr...

Yahoo - 2026-10-15

NEJM study supports CGM use for people with diabetes who don’t take insulin 🔗

The results come as Dexcom is awaiting a decision from the Centers for Medicare and Medicaid Services to expand Medicare coverage of the devices for p...

ChartMill - 2026-10-15

These S&P500 stocks that are showing activity before the opening bell on Thursday. 🔗

Stay updated with the S&P500 stocks that are on the move in today's pre-market session.

Yahoo - 2026-10-14

Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin 🔗

SAN DIEGO, October 14, 2026--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced that results from the landmark CONN...

Benzinga - 2026-10-14

DexCom's CONNECT Study Published In The New England Journal Of Medicine; Findings Support The Role Of CGM Earlier In Type 2 Diabetes Care For All People, Including Those Over The Age Of 65 🔗

Publication marks the first time in nearly two decades that The New England Journal of Medicine has published clinical data on standalone real-time co...

Yahoo - 2026-10-13

Here's Why You Should Retain DexCom Stock in Your Portfolio for Now 🔗

DexCom's strong margins, G7 15-day rollout and promising pipeline support its growth outlook, but factory ramp-up costs, forex and input-price pr...

Yahoo - 2026-10-13

mHealth Solutions Market Forecasts Growth from $109.05B (2026) to $275.44B by 2031, Profiling Philips, Medtronic, Abbott, Dexcom, ResMed & 20 Other Key Players 🔗

388-Page Report Delivers 2025 Market Share Rankings, Vendor Valuation Metrics and End-User Buying Criteria as Asia Pacific Emerges as the Fastest-Grow...